No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * |
KEGG DRUG * |
DrugBank |
指定難病告示番号 * |
1 | Acute myeloid leukemia 3 genes, 3 drugs (DrugBank) and 8 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
1件: RARA |
D06543 |
Vitamin A |
4件: 13, 49, 53, 90 |
2 | Adipocytokine signaling pathway 2 genes, 3 drugs (DrugBank) and 28 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
3 | Adrenergic signaling in cardiomyocytes 1 gene, 1 drug (DrugBank) and 7 diseases shown |
1件: SCN5A |
D01450 |
Bupivacaine |
7件: 46, 53, 70, 96, 168, 226, 298 |
D07552 |
4 | African trypanosomiasis 3 genes, 3 drugs (DrugBank) and 34 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
5 | AGE-RAGE signaling pathway in diabetic complications 3 genes, 4 drugs (DrugBank) and 29 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
6 | Alcoholism 2 genes, 1 drug (DrugBank) and 5 diseases shown |
2件: ADORA2A, ADORA2B |
D00045 |
Adenosine |
5件: 13, 46, 53, 58, 65 |
7 | Aldosterone-regulated sodium reabsorption 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
8 | Allograft rejection 5 genes, 4 drugs (DrugBank) and 43 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
9 | Alzheimer disease 6 genes, 4 drugs (DrugBank) and 65 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
10 | Amoebiasis 5 genes, 5 drugs (DrugBank) and 35 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
11 | Amphetamine addiction 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
12 | AMPK signaling pathway 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
13 | Amyotrophic lateral sclerosis (ALS) 6 genes, 4 drugs (DrugBank) and 65 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
14 | Antifolate resistance 4 genes, 4 drugs (DrugBank) and 46 diseases shown |
2件: DHFR, DHFR2 |
D00142 |
Methotrexate |
33件: 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
D02115 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
15 | Antigen processing and presentation 1 gene, 2 drugs (DrugBank) and 28 diseases shown |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
16 | Apoptosis 3 genes, 4 drugs (DrugBank) and 29 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
17 | Asthma 2 genes, 3 drugs (DrugBank) and 32 diseases shown |
1件: FCER1A |
D05251 |
Omalizumab |
6件: 53, 65, 98, 162, 226, 299 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
18 | Autoimmune thyroid disease 2 genes, 1 drug (DrugBank) and 24 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
19 | Autophagy - animal 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
20 | Axon guidance 6 genes, 3 drugs (DrugBank) and 56 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
21 | B cell receptor signaling pathway 7 genes, 4 drugs (DrugBank) and 57 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
22 | Bacterial invasion of epithelial cells 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
23 | Breast cancer 3 genes, 3 drugs (DrugBank) and 8 diseases shown |
2件: ESR1, ESR2 |
D11513 |
Estetrol |
1件: 53 |
D11514 |
D08409 |
Prasterone |
6件: 49, 53, 83, 86, 96, 113 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
24 | C-type lectin receptor signaling pathway 11 genes, 7 drugs (DrugBank) and 67 diseases shown |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
25 | Calcium signaling pathway 9 genes, 5 drugs (DrugBank) and 56 diseases shown |
2件: ADORA2A, ADORA2B |
D00045 |
Adenosine |
5件: 13, 46, 53, 58, 65 |
2件: CHRM2, CHRM3 |
D00525 |
Pilocarpine |
3件: 6, 53, 299 |
D02200 |
D05478 |
1件: CHRM3 |
D00661 |
Cevimeline |
1件: 53 |
D07667 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
26 | cAMP signaling pathway 5 genes, 4 drugs (DrugBank) and 10 diseases shown |
2件: ADORA1, ADORA2A |
D00045 |
Adenosine |
5件: 13, 46, 53, 58, 65 |
1件: CHRM2 |
D00525 |
Pilocarpine |
3件: 6, 53, 299 |
D02200 |
D05478 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
27 | Carbohydrate digestion and absorption 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
28 | Cell adhesion molecules (CAMs) 4 genes, 3 drugs (DrugBank) and 28 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
1件: PDCD1 |
D10316 |
Nivolumab |
10件: 13, 26, 41, 46, 49, 50, 51, 53, 96, 97 |
29 | Cellular senescence 7 genes, 4 drugs (DrugBank) and 57 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
30 | Central carbon metabolism in cancer 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
31 | cGMP-PKG signaling pathway 7 genes, 3 drugs (DrugBank) and 55 diseases shown |
2件: ADORA1, ADORA3 |
D00045 |
Adenosine |
5件: 13, 46, 53, 58, 65 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
32 | Chagas disease (American trypanosomiasis) 5 genes, 5 drugs (DrugBank) and 35 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
33 | Chemokine signaling pathway 2 genes, 2 drugs (DrugBank) and 5 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
34 | Choline metabolism in cancer 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
35 | Cholinergic synapse 3 genes, 3 drugs (DrugBank) and 5 diseases shown |
2件: CHRM2, CHRM3 |
D00525 |
Pilocarpine |
3件: 6, 53, 299 |
D02200 |
D05478 |
1件: CHRM3 |
D00661 |
Cevimeline |
1件: 53 |
D07667 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
36 | Chronic myeloid leukemia 2 genes, 2 drugs (DrugBank) and 5 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
37 | Cocaine addiction 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
38 | Colorectal cancer 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
39 | Cytokine-cytokine receptor interaction 8 genes, 6 drugs (DrugBank) and 44 diseases shown |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: IL6R |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
2件: LTA, TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
1件: LTB |
D08866 |
Baminercept |
4件: 13, 46, 53, 97 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
1件: TNFSF13B |
D03068 |
Belimumab |
8件: 11, 43, 44, 46, 49, 51, 53, 222 |
40 | Cytosolic DNA-sensing pathway 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
41 | Dilated cardiomyopathy (DCM) 1 gene, 2 drugs (DrugBank) and 28 diseases shown |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
42 | Dopaminergic synapse 4 genes, 3 drugs (DrugBank) and 58 diseases shown |
3件: PPP3CA, PPP3CB, PPP3CC |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: SCN1A |
D01450 |
Bupivacaine |
7件: 46, 53, 70, 96, 168, 226, 298 |
D07552 |
43 | Drug metabolism - other enzymes 2 genes, 3 drugs (DrugBank) and 36 diseases shown |
2件: IMPDH1, IMPDH2 |
D01392 |
Mizoribine |
8件: 46, 49, 51, 53, 66, 94, 222, 224 |
D00752 |
Mycophenolate mofetil |
32件: 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
D05094 |
D05095 |
D05096 |
Mycophenolic acid |
34件: 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
44 | EGFR tyrosine kinase inhibitor resistance 3 genes, 3 drugs (DrugBank) and 21 diseases shown |
1件: IL6R |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
45 | Endocrine and other factor-regulated calcium reabsorption 2 genes, 3 drugs (DrugBank) and 18 diseases shown |
1件: ESR1 |
D11513 |
Estetrol |
1件: 53 |
D11514 |
D08409 |
Prasterone |
6件: 49, 53, 83, 86, 96, 113 |
1件: VDR |
D00188 |
Cholecalciferol |
15件: 6, 13, 19, 20, 34, 46, 49, 53, 60, 65, 96, 97, 228, 298, 299 |
46 | Endocrine resistance 3 genes, 3 drugs (DrugBank) and 8 diseases shown |
2件: ESR1, ESR2 |
D11513 |
Estetrol |
1件: 53 |
D11514 |
D08409 |
Prasterone |
6件: 49, 53, 83, 86, 96, 113 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
47 | Endometrial cancer 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
48 | Epithelial cell signaling in Helicobacter pylori infection 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
49 | Epstein-Barr virus infection 5 genes, 6 drugs (DrugBank) and 34 diseases shown |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
50 | ErbB signaling pathway 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
51 | Estrogen signaling pathway 4 genes, 4 drugs (DrugBank) and 10 diseases shown |
2件: ESR1, ESR2 |
D11513 |
Estetrol |
1件: 53 |
D11514 |
D08409 |
Prasterone |
6件: 49, 53, 83, 86, 96, 113 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
1件: RARA |
D06543 |
Vitamin A |
4件: 13, 49, 53, 90 |
52 | Fc epsilon RI signaling pathway 3 genes, 4 drugs (DrugBank) and 33 diseases shown |
1件: FCER1A |
D05251 |
Omalizumab |
6件: 53, 65, 98, 162, 226, 299 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
53 | Fc gamma R-mediated phagocytosis 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
54 | Fluid shear stress and atherosclerosis 3 genes, 4 drugs (DrugBank) and 29 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
55 | Focal adhesion 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
56 | Folate biosynthesis 2 genes, 1 drug (DrugBank) and 33 diseases shown |
2件: DHFR, DHFR2 |
D00142 |
Methotrexate |
33件: 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
D02115 |
57 | FoxO signaling pathway 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
58 | Gastric acid secretion 1 gene, 2 drugs (DrugBank) and 3 diseases shown |
1件: CHRM3 |
D00661 |
Cevimeline |
1件: 53 |
D07667 |
D00525 |
Pilocarpine |
3件: 6, 53, 299 |
D02200 |
D05478 |
59 | Gastric cancer 2 genes, 2 drugs (DrugBank) and 6 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
1件: RARB |
D06543 |
Vitamin A |
4件: 13, 49, 53, 90 |
60 | Glioma 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
61 | Glucagon signaling pathway 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
62 | Glutamatergic synapse 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
63 | GnRH secretion 2 genes, 3 drugs (DrugBank) and 8 diseases shown |
1件: ESR2 |
D11513 |
Estetrol |
1件: 53 |
D11514 |
D08409 |
Prasterone |
6件: 49, 53, 83, 86, 96, 113 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
64 | Graft-versus-host disease 3 genes, 3 drugs (DrugBank) and 40 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
65 | Growth hormone synthesis, secretion and action 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
66 | Hematopoietic cell lineage 3 genes, 4 drugs (DrugBank) and 59 diseases shown |
1件: IL6R |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
1件: MS4A1 |
D02994 |
Rituximab |
42件: 11, 13, 14, 17, 35, 36, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 223, 229, 256, 271, 283, 284, 285, 288, 300, 331 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
67 | Hepatitis B 4 genes, 5 drugs (DrugBank) and 30 diseases shown |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
68 | Hepatitis C 4 genes, 5 drugs (DrugBank) and 30 diseases shown |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
69 | Hepatocellular carcinoma 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
70 | Herpes simplex virus 1 infection 7 genes, 6 drugs (DrugBank) and 36 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
2件: LTA, TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
71 | HIF-1 signaling pathway 3 genes, 3 drugs (DrugBank) and 18 diseases shown |
1件: IL6R |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
72 | Human cytomegalovirus infection 10 genes, 8 drugs (DrugBank) and 69 diseases shown |
1件: IL6R |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
73 | Human immunodeficiency virus 1 infection 8 genes, 6 drugs (DrugBank) and 65 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
74 | Human papillomavirus infection 4 genes, 5 drugs (DrugBank) and 30 diseases shown |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
75 | Human T-cell leukemia virus 1 infection 11 genes, 8 drugs (DrugBank) and 66 diseases shown |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
2件: LTA, TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
76 | Hypertrophic cardiomyopathy (HCM) 1 gene, 2 drugs (DrugBank) and 28 diseases shown |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
77 | IL-17 signaling pathway 2 genes, 3 drugs (DrugBank) and 28 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
78 | Inflammatory bowel disease (IBD) 5 genes, 4 drugs (DrugBank) and 34 diseases shown |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
79 | Inflammatory mediator regulation of TRP channels 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
80 | Influenza A 6 genes, 6 drugs (DrugBank) and 36 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
81 | Inositol phosphate metabolism 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
82 | Insulin resistance 3 genes, 4 drugs (DrugBank) and 29 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
83 | Insulin secretion 1 gene, 2 drugs (DrugBank) and 3 diseases shown |
1件: CHRM3 |
D00661 |
Cevimeline |
1件: 53 |
D07667 |
D00525 |
Pilocarpine |
3件: 6, 53, 299 |
D02200 |
D05478 |
84 | Insulin signaling pathway 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
85 | Intestinal immune network for IgA production 3 genes, 2 drugs (DrugBank) and 25 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
1件: TNFSF13B |
D03068 |
Belimumab |
8件: 11, 43, 44, 46, 49, 51, 53, 222 |
86 | JAK-STAT signaling pathway 6 genes, 4 drugs (DrugBank) and 29 diseases shown |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: IL6R |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
87 | Kaposi sarcoma-associated herpesvirus infection 9 genes, 6 drugs (DrugBank) and 62 diseases shown |
1件: CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
88 | Legionellosis 4 genes, 4 drugs (DrugBank) and 34 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
89 | Leishmaniasis 5 genes, 5 drugs (DrugBank) and 35 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
90 | Leukocyte transendothelial migration 2 genes, 2 drugs (DrugBank) and 10 diseases shown |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
91 | Long-term potentiation 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
92 | Longevity regulating pathway 2 genes, 2 drugs (DrugBank) and 5 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
93 | Longevity regulating pathway - multiple species 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
94 | Malaria 3 genes, 4 drugs (DrugBank) and 37 diseases shown |
1件: IL12A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
95 | MAPK signaling pathway 7 genes, 5 drugs (DrugBank) and 65 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
96 | Measles 5 genes, 4 drugs (DrugBank) and 19 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
97 | Melanoma 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
98 | Metabolic pathways 6 genes, 6 drugs (DrugBank) and 51 diseases shown |
2件: DHFR, DHFR2 |
D00142 |
Methotrexate |
33件: 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
D02115 |
1件: DHODH |
D00749 |
Leflunomide |
10件: 11, 40, 46, 49, 53, 66, 162, 224, 271, 300 |
2件: IMPDH1, IMPDH2 |
D01392 |
Mizoribine |
8件: 46, 49, 51, 53, 66, 94, 222, 224 |
D00752 |
Mycophenolate mofetil |
32件: 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
D05094 |
D05095 |
D05096 |
Mycophenolic acid |
34件: 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
99 | MicroRNAs in cancer 2 genes, 2 drugs (DrugBank) and 5 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
100 | Mineral absorption 1 gene, 1 drug (DrugBank) and 15 diseases shown |
1件: VDR |
D00188 |
Cholecalciferol |
15件: 6, 13, 19, 20, 34, 46, 49, 53, 60, 65, 96, 97, 228, 298, 299 |
101 | Morphine addiction 1 gene, 1 drug (DrugBank) and 5 diseases shown |
1件: ADORA1 |
D00045 |
Adenosine |
5件: 13, 46, 53, 58, 65 |
102 | mTOR signaling pathway 2 genes, 3 drugs (DrugBank) and 29 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
103 | Natural killer cell mediated cytotoxicity 8 genes, 6 drugs (DrugBank) and 66 diseases shown |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
104 | Necroptosis 2 genes, 3 drugs (DrugBank) and 29 diseases shown |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
105 | Neuroactive ligand-receptor interaction 7 genes, 7 drugs (DrugBank) and 55 diseases shown |
4件: ADORA1, ADORA2A, ADORA2B, ADORA3 |
D00045 |
Adenosine |
5件: 13, 46, 53, 58, 65 |
2件: CHRM2, CHRM3 |
D00525 |
Pilocarpine |
3件: 6, 53, 299 |
D02200 |
D05478 |
1件: CHRM3 |
D00661 |
Cevimeline |
1件: 53 |
D07667 |
1件: NR3C1 |
D00292 |
Dexamethasone |
20件: 13, 16, 28, 35, 46, 53, 63, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 222, 296, 299 |
D00975 |
D01510 |
D01615 |
D01632 |
D01948 |
D02174 |
D02591 |
D02592 |
D00088 |
Hydrocortisone |
8件: 6, 53, 75, 78, 81, 83, 97, 299 |
D00165 |
Hydrocortisone acetate |
8件: 6, 53, 75, 78, 81, 83, 97, 299 |
D00473 |
Prednisone |
44件: 2, 11, 13, 14, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 95, 96, 97, 113, 145, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 |
106 | Neurotrophin signaling pathway 2 genes, 2 drugs (DrugBank) and 5 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
107 | NF-kappa B signaling pathway 5 genes, 5 drugs (DrugBank) and 33 diseases shown |
2件: LTA, TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
1件: LTB |
D08866 |
Baminercept |
4件: 13, 46, 53, 97 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
1件: TNFSF13B |
D03068 |
Belimumab |
8件: 11, 43, 44, 46, 49, 51, 53, 222 |
108 | NOD-like receptor signaling pathway 3 genes, 4 drugs (DrugBank) and 29 diseases shown |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
109 | Non-alcoholic fatty liver disease (NAFLD) 4 genes, 5 drugs (DrugBank) and 38 diseases shown |
1件: IL6R |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
110 | Non-small cell lung cancer 2 genes, 2 drugs (DrugBank) and 6 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
1件: RARB |
D06543 |
Vitamin A |
4件: 13, 49, 53, 90 |
111 | One carbon pool by folate 2 genes, 1 drug (DrugBank) and 33 diseases shown |
2件: DHFR, DHFR2 |
D00142 |
Methotrexate |
33件: 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
D02115 |
112 | Oocyte meiosis 6 genes, 3 drugs (DrugBank) and 56 diseases shown |
1件: AR |
D08409 |
Prasterone |
6件: 49, 53, 83, 86, 96, 113 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
113 | Osteoclast differentiation 9 genes, 7 drugs (DrugBank) and 65 diseases shown |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
114 | Oxytocin signaling pathway 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
115 | Pancreatic cancer 3 genes, 3 drugs (DrugBank) and 8 diseases shown |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
116 | Pancreatic secretion 1 gene, 2 drugs (DrugBank) and 3 diseases shown |
1件: CHRM3 |
D00661 |
Cevimeline |
1件: 53 |
D07667 |
D00525 |
Pilocarpine |
3件: 6, 53, 299 |
D02200 |
D05478 |
117 | Parathyroid hormone synthesis, secretion and action 1 gene, 1 drug (DrugBank) and 15 diseases shown |
1件: VDR |
D00188 |
Cholecalciferol |
15件: 6, 13, 19, 20, 34, 46, 49, 53, 60, 65, 96, 97, 228, 298, 299 |
118 | Parkinson disease 1 gene, 1 drug (DrugBank) and 5 diseases shown |
1件: ADORA2A |
D00045 |
Adenosine |
5件: 13, 46, 53, 58, 65 |
119 | Pathogenic Escherichia coli infection 2 genes, 3 drugs (DrugBank) and 28 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
120 | Pathways in cancer 12 genes, 8 drugs (DrugBank) and 32 diseases shown |
3件: AR, ESR1, ESR2 |
D08409 |
Prasterone |
6件: 49, 53, 83, 86, 96, 113 |
2件: ESR1, ESR2 |
D11513 |
Estetrol |
1件: 53 |
D11514 |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: IL6R |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
2件: RARA, RARB |
D06543 |
Vitamin A |
4件: 13, 49, 53, 90 |
121 | PD-L1 expression and PD-1 checkpoint pathway in cancer 9 genes, 6 drugs (DrugBank) and 57 diseases shown |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PDCD1 |
D10316 |
Nivolumab |
10件: 13, 26, 41, 46, 49, 50, 51, 53, 96, 97 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
122 | Pertussis 5 genes, 4 drugs (DrugBank) and 34 diseases shown |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
123 | Phosphatidylinositol signaling system 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
124 | Phospholipase D signaling pathway 2 genes, 2 drugs (DrugBank) and 8 diseases shown |
1件: FCER1A |
D05251 |
Omalizumab |
6件: 53, 65, 98, 162, 226, 299 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
125 | PI3K-Akt signaling pathway 5 genes, 5 drugs (DrugBank) and 23 diseases shown |
1件: CHRM2 |
D00525 |
Pilocarpine |
3件: 6, 53, 299 |
D02200 |
D05478 |
1件: IL6R |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
126 | Platelet activation 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
127 | Platinum drug resistance 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
128 | Progesterone-mediated oocyte maturation 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
129 | Prolactin signaling pathway 4 genes, 4 drugs (DrugBank) and 10 diseases shown |
2件: ESR1, ESR2 |
D11513 |
Estetrol |
1件: 53 |
D11514 |
D08409 |
Prasterone |
6件: 49, 53, 83, 86, 96, 113 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
130 | Prostate cancer 3 genes, 3 drugs (DrugBank) and 10 diseases shown |
1件: AR |
D08409 |
Prasterone |
6件: 49, 53, 83, 86, 96, 113 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
131 | Proteoglycans in cancer 4 genes, 6 drugs (DrugBank) and 38 diseases shown |
1件: ESR1 |
D11513 |
Estetrol |
1件: 53 |
D11514 |
D08409 |
Prasterone |
6件: 49, 53, 83, 86, 96, 113 |
1件: IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
132 | Purine metabolism 2 genes, 3 drugs (DrugBank) and 36 diseases shown |
2件: IMPDH1, IMPDH2 |
D01392 |
Mizoribine |
8件: 46, 49, 51, 53, 66, 94, 222, 224 |
D00752 |
Mycophenolate mofetil |
32件: 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
D05094 |
D05095 |
D05096 |
Mycophenolic acid |
34件: 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
133 | Pyrimidine metabolism 1 gene, 1 drug (DrugBank) and 10 diseases shown |
1件: DHODH |
D00749 |
Leflunomide |
10件: 11, 40, 46, 49, 53, 66, 162, 224, 271, 300 |
134 | Rap1 signaling pathway 4 genes, 3 drugs (DrugBank) and 12 diseases shown |
2件: ADORA2A, ADORA2B |
D00045 |
Adenosine |
5件: 13, 46, 53, 58, 65 |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
135 | Ras signaling pathway 2 genes, 2 drugs (DrugBank) and 5 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
136 | Regulation of actin cytoskeleton 4 genes, 4 drugs (DrugBank) and 12 diseases shown |
2件: CHRM2, CHRM3 |
D00525 |
Pilocarpine |
3件: 6, 53, 299 |
D02200 |
D05478 |
1件: CHRM3 |
D00661 |
Cevimeline |
1件: 53 |
D07667 |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
137 | Regulation of lipolysis in adipocytes 2 genes, 2 drugs (DrugBank) and 7 diseases shown |
1件: ADORA1 |
D00045 |
Adenosine |
5件: 13, 46, 53, 58, 65 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
138 | Relaxin signaling pathway 2 genes, 2 drugs (DrugBank) and 5 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
139 | Renal cell carcinoma 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
140 | Renin secretion 6 genes, 3 drugs (DrugBank) and 55 diseases shown |
1件: ADORA1 |
D00045 |
Adenosine |
5件: 13, 46, 53, 58, 65 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
141 | Rheumatoid arthritis 7 genes, 7 drugs (DrugBank) and 46 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
1件: IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
1件: LTB |
D08866 |
Baminercept |
4件: 13, 46, 53, 97 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
1件: TNFSF13B |
D03068 |
Belimumab |
8件: 11, 43, 44, 46, 49, 51, 53, 222 |
142 | RIG-I-like receptor signaling pathway 4 genes, 4 drugs (DrugBank) and 34 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
143 | Salivary secretion 1 gene, 2 drugs (DrugBank) and 3 diseases shown |
1件: CHRM3 |
D00661 |
Cevimeline |
1件: 53 |
D07667 |
D00525 |
Pilocarpine |
3件: 6, 53, 299 |
D02200 |
D05478 |
144 | Salmonella infection 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
145 | Shigellosis 3 genes, 4 drugs (DrugBank) and 29 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
146 | Signaling pathways regulating pluripotency of stem cells 2 genes, 2 drugs (DrugBank) and 8 diseases shown |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
147 | Small cell lung cancer 3 genes, 3 drugs (DrugBank) and 8 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
1件: RARB |
D06543 |
Vitamin A |
4件: 13, 49, 53, 90 |
148 | Sphingolipid signaling pathway 6 genes, 6 drugs (DrugBank) and 35 diseases shown |
2件: ADORA1, ADORA3 |
D00045 |
Adenosine |
5件: 13, 46, 53, 58, 65 |
1件: FCER1A |
D05251 |
Omalizumab |
6件: 53, 65, 98, 162, 226, 299 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
149 | Staphylococcus aureus infection 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
150 | Systemic lupus erythematosus 3 genes, 3 drugs (DrugBank) and 40 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
151 | T cell receptor signaling pathway 9 genes, 7 drugs (DrugBank) and 65 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PDCD1 |
D10316 |
Nivolumab |
10件: 13, 26, 41, 46, 49, 50, 51, 53, 96, 97 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
152 | Taste transduction 4 genes, 3 drugs (DrugBank) and 9 diseases shown |
1件: CHRM3 |
D00661 |
Cevimeline |
1件: 53 |
D07667 |
D00525 |
Pilocarpine |
3件: 6, 53, 299 |
D02200 |
D05478 |
3件: SCN2A, SCN3A, SCN9A |
D01450 |
Bupivacaine |
7件: 46, 53, 70, 96, 168, 226, 298 |
D07552 |
153 | TGF-beta signaling pathway 1 gene, 2 drugs (DrugBank) and 28 diseases shown |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
154 | Th1 and Th2 cell differentiation 9 genes, 5 drugs (DrugBank) and 59 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
155 | Th17 cell differentiation 10 genes, 7 drugs (DrugBank) and 64 diseases shown |
1件: IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: IL6R |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: RARA |
D06543 |
Vitamin A |
4件: 13, 49, 53, 90 |
156 | Thyroid hormone signaling pathway 2 genes, 3 drugs (DrugBank) and 8 diseases shown |
1件: ESR1 |
D11513 |
Estetrol |
1件: 53 |
D11514 |
D08409 |
Prasterone |
6件: 49, 53, 83, 86, 96, 113 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
157 | TNF signaling pathway 4 genes, 4 drugs (DrugBank) and 29 diseases shown |
2件: LTA, TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
158 | Toll-like receptor signaling pathway 7 genes, 6 drugs (DrugBank) and 44 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
159 | Toxoplasmosis 5 genes, 5 drugs (DrugBank) and 35 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
160 | Transcriptional misregulation in cancer 3 genes, 3 drugs (DrugBank) and 25 diseases shown |
1件: CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: RARA |
D06543 |
Vitamin A |
4件: 13, 49, 53, 90 |
161 | Tuberculosis 12 genes, 8 drugs (DrugBank) and 69 diseases shown |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
1件: VDR |
D00188 |
Cholecalciferol |
15件: 6, 13, 19, 20, 34, 46, 49, 53, 60, 65, 96, 97, 228, 298, 299 |
162 | Type I diabetes mellitus 6 genes, 4 drugs (DrugBank) and 43 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
2件: LTA, TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
163 | Type II diabetes mellitus 2 genes, 3 drugs (DrugBank) and 29 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
164 | Vascular smooth muscle contraction 2 genes, 1 drug (DrugBank) and 5 diseases shown |
2件: ADORA2A, ADORA2B |
D00045 |
Adenosine |
5件: 13, 46, 53, 58, 65 |
165 | VEGF signaling pathway 6 genes, 3 drugs (DrugBank) and 56 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
166 | Viral carcinogenesis 3 genes, 3 drugs (DrugBank) and 8 diseases shown |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
167 | Viral myocarditis 3 genes, 2 drugs (DrugBank) and 27 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
168 | Viral protein interaction with cytokine and cytokine receptor 3 genes, 3 drugs (DrugBank) and 37 diseases shown |
1件: IL6R |
D02596 |
Tocilizumab |
16件: 2, 13, 40, 41, 43, 46, 50, 51, 53, 54, 55, 86, 107, 266, 271, 331 |
2件: LTA, TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
1件: TNF |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
169 | Wnt signaling pathway 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
170 | Yersinia infection 3 genes, 4 drugs (DrugBank) and 29 diseases shown |
1件: NFKB1 |
D01146 |
Iguratimod |
3件: 46, 53, 271 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
1件: TNF |
D00742 |
Etanercept |
15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 |
D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |